Long‐term benzodiazepines and z‐drug prescribing in Australian general practice between 2011 and 2018: A national study
Open Access
- 17 December 2021
- journal article
- research article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 10 (1) , e00896
Abstract
Despite reducing benzodiazepine prescribing, benzodiazepine‐involving deaths have substantially increased in Australia. This study aimed to explore patterns in long‐term prescribing of medications (benzodiazepine and z‐drugs [BZD]) used for sleep‐issues/insomnia in Australia to better understand these changes. Open cohort study using de‐identified electronic health records of 1 414 593 adult patients regularly attending 404 Australian general practices from 2011 to 2018 (MedicineInsight). We used logistic regression adjusted for patient and practice characteristics to; (1) estimate long‐term BZD prescribing prevalence (≥3 prescriptions in 6 months) and the associated sociodemographic factors, and (2) Poisson regression to compute annual changes in prescribing rates. Long‐term BZD prescribing changed from 4.4% in 2011 to 5.8% in 2015, remaining relatively stable until 2018 (annual increase +2.5% [95% CI +2.0%;+3.0%]). Long‐term BZD prescribing in any year was up to six times more likely in elderly rather than in younger patients and 30%–43% more prevalent in females, or patients living in or attending a practice located in more disadvantaged areas. The increase was more pronounced among males, adults aged 35–49 years, and individuals living in advantaged areas. The median duration among incident cases decreased from 1183 to 322 days between 2011 and 2017, and was up to 197 days longer among elderly females than males. Despite a slight increase and recent stability in long‐term BZD prescribing, the higher rates and durations among elderly patients, women, or those living in more disadvantaged areas are concerning and highlights the need for interventions that reduce the potential harms of long‐term BZD use in vulnerable groups.Keywords
Funding Information
- Royal Australian College of General Practitioners
This publication has 32 references indexed in Scilit:
- Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013American Journal of Public Health, 2016
- Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database studyPain, 2016
- Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studiesEuropean Psychiatry, 2015
- The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) StatementPLOS Medicine, 2015
- Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort studyBMJ, 2014
- Twenty‐year trends in benzodiazepine dispensing in the Australian populationInternal Medicine Journal, 2014
- Benzodiazepine harm: how can it be reduced?British Journal of Clinical Pharmacology, 2014
- Long‐term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugsPharmacoepidemiology and Drug Safety, 2011
- Sleep and its disorders in aging populationsSleep Medicine, 2009
- Use of Benzodiazepines and Selective Serotonin Reuptake Inhibitors in Middle-Aged and Older Adults With Anxiety Disorders: A Longitudinal and Prospective StudyThe American Journal of Geriatric Psychiatry, 2008